New insights into clinical trial for colostrinin™ in Alzheimer’s disease

Background The pathomechanism of Alzheimer’s disease (AD) is multifactorial although the most popular hypotheses are centered on the effects of the misfolded, aggregated protein, amyloid beta (Aβ) and on Tau hyperphosphorylation.